These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10115798)

  • 41. Legal issues affecting IPA formation.
    King JP
    Healthc Financ Manage; 1995 Nov; 49(11):24-6, 28. PubMed ID: 10151864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HMOs' grasp on drug benefits is getting stronger.
    Traska MR
    Hospitals; 1986 Apr; 60(8):68. PubMed ID: 3957318
    [No Abstract]   [Full Text] [Related]  

  • 43. A short history of capitation.
    Russ Coiles Health Trends; 1996 Apr; 8(6):8, 7. PubMed ID: 10156044
    [No Abstract]   [Full Text] [Related]  

  • 44. No tax exemption for Geisinger Health Plan. Geisinger Health Plan v. Commissioner.
    Driscoll TL
    Health Care Law Newsl; 1993 Aug; 8(8):20-2. PubMed ID: 10183917
    [No Abstract]   [Full Text] [Related]  

  • 45. Does managed care contain costs?
    Wolfe PR
    Internist; 1993 May; 34(5):9-12. PubMed ID: 10126007
    [No Abstract]   [Full Text] [Related]  

  • 46. California physicians struggling--problems ahead for other states?
    Dalzell MD
    Manag Care; 1999 Oct; 8(10):45-8. PubMed ID: 10661951
    [No Abstract]   [Full Text] [Related]  

  • 47. IRS claims IPAs are out for profit.
    Stacey J
    Am Med News; 1982 May; 25(17):3, 14. PubMed ID: 10255832
    [No Abstract]   [Full Text] [Related]  

  • 48. HMOs' stock debacle changes the game.
    Johnson DE
    Health Care Strateg Manage; 1996 Aug; 14(8):2-3. PubMed ID: 10159391
    [No Abstract]   [Full Text] [Related]  

  • 49. HMOs' 1997 losses may continue to affect providers in 1999.
    Manag Care Strateg; 1998 Jul; 6(7):73-5. PubMed ID: 10181529
    [No Abstract]   [Full Text] [Related]  

  • 50. New Geisinger II health care organizations tax-exemption test is no improvement on prior model.
    Mills EM
    Healthspan; 1994 Nov; 11(10):3-6. PubMed ID: 10184230
    [No Abstract]   [Full Text] [Related]  

  • 51. The family physician and HMO/IPA contracts.
    Bradley DW; Estes EH
    J Fam Pract; 1988 Mar; 26(3):257-8. PubMed ID: 3126259
    [No Abstract]   [Full Text] [Related]  

  • 52. Marketplace. Festering dispute headed for court: do nonprofit HMOs have to shift risk?
    Moskowitz DB
    Med Health; 1999 Jul; 53(29):suppl 1-2. PubMed ID: 10539193
    [No Abstract]   [Full Text] [Related]  

  • 53. HMOs' savings have 'spillover effect'--studies.
    Kenkel PJ
    Mod Healthc; 1992 Jan; 22(2):30-1. PubMed ID: 10115804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolving HMO business practices can threaten tax-exempt status.
    Vecchioni MP
    Healthc Financ Manage; 1997 Sep; 51(9):45-8. PubMed ID: 10170316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Value of keeping HMOs competitive.
    Doherty JF
    Natl Underwrit Life Health; 1982 Apr; 86(16):26-7, 30. PubMed ID: 10255724
    [No Abstract]   [Full Text] [Related]  

  • 56. Lawsuit looms over HMOs' home-care responsibilities.
    Lutz S
    Mod Healthc; 1991 Feb; 21(7):10. PubMed ID: 10109158
    [No Abstract]   [Full Text] [Related]  

  • 57. Medicare prospective pay plan dims HMOs' enrollment hopes.
    Staver S
    Am Med News; 1983 Jan; 26(4):1-2, 19. PubMed ID: 10324814
    [No Abstract]   [Full Text] [Related]  

  • 58. Ruling influences HMO valuations, reimbursement.
    Traska MR
    Hospitals; 1988 Jun; 62(11):47-8. PubMed ID: 3131232
    [No Abstract]   [Full Text] [Related]  

  • 59. Risk management in an IPA setting--Part I.
    Harding J
    Physician Exec; 1994 May; 20(5):32-7. PubMed ID: 10134063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.